Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib)
NCT00964028
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Haemophilus Influenzae Type b
Acellular Pertussis
Diphtheria
Tetanus
Poliomyelitis
Interventions
BIOLOGICAL:
Infanrix™-IPV/Hib
Sponsor
GlaxoSmithKline